所有图片(1)
别名:
Poly(vinyl acetate) dispersion 30 %, Poly(vinyl acetate) stabilized with polyvinylpyrrolidone and sodium lauryl sulfate
推荐产品
质量水平
检测方案
25.0-30.0% (saponification value * 0.1534)
28.5-31.5% solids basis
形式
dispersion
杂质
≤0.5% sulfated ash (verified on random samples only)
≤0.500% particulate matter, agglomerates
≤100 ppm residual monomer vinyl acetate
≤15000 ppm acetic acid
≤20 ppm heavy metals (verified on random samples only)
≤4.0% povidone (N content/0.126)
pH值（酸碱度）
3.0-5.5
粘度
≤100 mPa.s(20 °C, Brookfield RVT) (SP. 1, 100 PRM)
密度
1.045-1.065
InChI
1S/C4H6O2/c1-3-6-4(2)5/h3H,1H2,2H3
InChI key
XTXRWKRVRITETP-UHFFFAOYSA-N
应用
Kollicoat SR is use as a controlled-release coating or as a matrix. Kollicoat polymers can be employed as film coatings (intelligent surfaces) with controlled-release agents, for instant-release or sustained-release applications. Kollicoat polymers can be used with all standard coating equipment and are cost-effective, delivering maximum quality in terms of function, stability, and appearance. This research grade product is intended for use in R&D and development only.
分析说明
appearance and solubility of a film must conform
法律信息
Kollicoat is a registered trademark of BASF SE
WGK
WGK 1
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Sandra Strübing et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 69(2), 708-717 (2008-02-06)
The purpose of this study was to investigate the mechanism of floating and drug release behaviour of poly(vinyl acetate)-based floating tablets with membrane controlled drug delivery. Propranolol HCl containing tablets with Kollidon SR as an excipient for direct compression and
Nizar Al-Zoubi et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 69(2), 735-742 (2008-02-23)
Sustained-release of buspirone HCl (BUH) was attempted by spray drying after dissolving in two commercially available aqueous polymeric dispersions (Eudragit RS 30 D or Kollicoat SR 30 D) at five different drug:polymer ratios (1:1, 1:2, 1:3, 1:6 and 1:9). The
Wiesław Sawicki et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 60(1), 153-158 (2005-04-26)
The purpose of this study was to work out a method of compression of floating pellets with verapamil hydrochloride (VH) in a dose of 40 mg. It was assumed that this form should reside in the stomach floating for several
Seon Tae Kim et al.
International journal of pediatric otorhinolaryngology, 77(1), 113-116 (2012-11-08)
The purpose of this prospective study was to determine the effectiveness of polyurethane foam (PUF) and polyvinyl acetate (PA) as packing materials for reducing post-conchotomy bleeding, pain, and headaches. This study was a prospective, randomized and single-blinded controlled study. Fifty-two
Priscileila Colerato Ferrari et al.
Carbohydrate polymers, 91(1), 244-252 (2012-10-10)
In this work pellets containing chitosan for colonic drug delivery were developed. The influence of the polysaccharide in the pellets was evaluated by swelling, drug dissolution and intestinal permeation studies. Drug-loaded pellets containing chitosan as swellable polymer were coated with
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门